Tina Cheng
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Oncology top 2%
- Cancer Research top 5%
- Surgery top 10%
- Co-authors
- Scott NorthChristian KollmannsbergerDaniel Y.C. HengToni K. ChoueiriBrian I. RiniJennifer J. KnoxDavid F. McDermottMark Warren
- Topics
- Cancer Immunotherapy and Biomarkers (23 papers)CAR-T cell therapy research (16 papers)Immunotherapy and Immune Responses (7 papers)
- Partner nations
- CanadaUnited StatesIndia
In The Last Decade
Tina Cheng
37 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 1.0k
- Oncology 1.0k
- Cancer Research 633
- Surgery 347
Countries citing papers authored by Tina Cheng
This map shows the geographic impact of Tina Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Cheng more than expected).
Fields of papers citing papers by Tina Cheng
This network shows the impact of papers produced by Tina Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Cheng. The network helps show where Tina Cheng may publish in the future.
Co-authorship network of co-authors of Tina Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Tina Cheng. A scholar is included among the top collaborators of Tina Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina Cheng. Tina Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 6 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 32 | |
| 8 | 5 | |
| 9 | 14 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 25 | |
| 13 | 46 | |
| 14 | 3 | |
| 15 | 1 | |
| 16 | 20 | |
| 17 | 72 | |
| 18 | Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Studybreakdown → | 1525 |
| 19 | 9 | |
| 20 | 100 |
About Tina Cheng
Tina Cheng is a scholar working on Oncology, Ophthalmology and Hematology, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), CAR-T cell therapy research (16 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Cancer Research (633 citations) and Oncology (1.0k citations). Tina Cheng has collaborated with scholars based in Canada, United States and India. Frequent co-authors include Scott North, Christian Kollmannsberger, Daniel Y.C. Heng, Toni K. Choueiri, Brian I. Rini, Jennifer J. Knox, David F. McDermott, Mark Warren, Peter Venner and Bernhard J. Eigl. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.